NCCN publishes new recommendations for treating children with brain tumors

The Lilabean Foundation for Pediatric Brain Cancer raises $900K

The Lilabean Foundation for Pediatric Brain Cancer Research raised $900,000 at its 13th Annual Lilabean Foundation Fall Ball, held on Saturday, November 2. Proceeds from the Fall Ball will directly fund groundbreaking research initiatives focused on discovering new treatments and improving survival rates for children fighting pediatric brain cancer.

November 22, 2024

Vol.50 No.44

Clinical Roundup

NCCN updates CML treatment guidelines following FDA approval of Scemblix for newly diagnosed patients

The National Comprehensive Cancer Network updated its chronic myeloid leukemia treatment guidelines, recommending Scemblix (asciminib) for the treatment of adults with newly diagnosed Ph+ CML-CP as a category 1-preferred.

November 22, 2024

Vol.50 No.44

In Brief

SU2C announces grants supporting research in six cancer types

Stand Up To Cancer announced grants to several teams of leading cancer investigators in support of cutting-edge research in a variety of cancers including head and neck, pediatric, pancreatic, breast, rectal, and gastro-esophageal cancers, as well as research focused on how the microbiome communicates with the immune system.

October 18, 2024

Vol.50 No.39

In Brief

Cigall Kadoch wins $250,000 Blavatnik National Award

Cigall Kadoch was named the laureate of the Blavatnik National Awards for Young Scientists in the field of life sciences for her work in cancer biology.

September 20, 2024

Vol.50 No.35

In Brief

Cheng-Chia Wu receives St. Baldrick’s grant to support focused ultrasound research for DIPG and DMG

Cheng-Chia “Fred” Wu, assistant professor at Fralin Biomedical Research Institute at Virginia Tech Carilion, received a $115,000 extended scholar grant from St. Baldrick’s to support focused ultrasound research for the treatment of diffuse midline glioma and diffuse intrinsic pontine glioma.

September 13, 2024

Vol.50 No.34

In Brief

Washington University in St. Louis receives $2M from CureSearch for pediatric brain cancer phase I study

CureSearch for Children’s Cancer will award $2 million in funding to support a phase I clinical trial in 24 children and young adults with recurrent brain tumors.

September 06, 2024

Vol.50 No.33

NCCN publishes new recommendations for treating children with brain tumors

YOU MAY BE INTERESTED IN

The Lilabean Foundation for Pediatric Brain Cancer raises $900K

NCCN updates CML treatment guidelines following FDA approval of Scemblix for newly diagnosed patients

SU2C announces grants supporting research in six cancer types

Cigall Kadoch wins $250,000 Blavatnik National Award

Cheng-Chia Wu receives St. Baldrick’s grant to support focused ultrasound research for DIPG and DMG

Washington University in St. Louis receives $2M from CureSearch for pediatric brain cancer phase I study

Renew today!

Subscriber content

Never miss an issue!

Login